| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |